| Good Neighbor Hospice 1122 N Main Ste B, Muskogee, OK, 74401 | |
| (918) 681-4988 |
News Archive
The move is designed to reduce the risk of unnecessary surgery, but some physicians may resist the effort. Women with low-risk pregnancies should be allowed to spend more time in labor, to reduce the risk of having an unnecessary C-section, the nation's obstetricians say.
Commenting on Edward Boyden's article, Ben Barres, Head of the Neuronal & Glial Cell Biology Section of Faculty of 1000 and Professor at Stanford University School of Medicine said: "There will probably be a Nobel prize for optogenetics someday as it has revolutionized our attempts to understand how the brain works. This article provides a fascinating insight into the birth of optogenetics and the roles of the major players."
Top Institute Pharma (TI Pharma) enables unique public-private collaborations that are extremely valuable for pharmaceutical research in the Netherlands. This can be read in the Midterm Review (MTR) of the Top Institute, which was published today. In the report, an independent committee chaired by Cees Veerman concludes that TI Pharma is well on its way to achieving the objectives that were determined at the time of its establishment. The institute addresses issues with marked social relevance, attracts international investments and has brought forth a group of quality researchers.
Health costs per person in Minnesota rose only 2.6 percent in 2010, about half the national average. Key factors in controlling costs were innovations by Minnesota's health plans – for example, more effective management of care for those with chronic diseases – and reduced demand for health care in a slow economy.
Schering-Plough Corporation today reported a proposed settlement, subject to Court approval, to resolve litigation seeking to enjoin the planned merger with Merck & Co., Inc., and other forms of relief.
› Verified 7 days ago
| Name | Good Neighbor Hospice |
|---|---|
| Location | 1122 N Main Ste B, Muskogee, Oklahoma |
| Hospice ID | 371692 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Other |
| Profit Type | FOR PROFIT |
| SSA county code | 500 |
News Archive
The move is designed to reduce the risk of unnecessary surgery, but some physicians may resist the effort. Women with low-risk pregnancies should be allowed to spend more time in labor, to reduce the risk of having an unnecessary C-section, the nation's obstetricians say.
Commenting on Edward Boyden's article, Ben Barres, Head of the Neuronal & Glial Cell Biology Section of Faculty of 1000 and Professor at Stanford University School of Medicine said: "There will probably be a Nobel prize for optogenetics someday as it has revolutionized our attempts to understand how the brain works. This article provides a fascinating insight into the birth of optogenetics and the roles of the major players."
Top Institute Pharma (TI Pharma) enables unique public-private collaborations that are extremely valuable for pharmaceutical research in the Netherlands. This can be read in the Midterm Review (MTR) of the Top Institute, which was published today. In the report, an independent committee chaired by Cees Veerman concludes that TI Pharma is well on its way to achieving the objectives that were determined at the time of its establishment. The institute addresses issues with marked social relevance, attracts international investments and has brought forth a group of quality researchers.
Health costs per person in Minnesota rose only 2.6 percent in 2010, about half the national average. Key factors in controlling costs were innovations by Minnesota's health plans – for example, more effective management of care for those with chronic diseases – and reduced demand for health care in a slow economy.
Schering-Plough Corporation today reported a proposed settlement, subject to Court approval, to resolve litigation seeking to enjoin the planned merger with Merck & Co., Inc., and other forms of relief.
› Verified 7 days ago
| NPI Number | 1881883148 |
| Organization Name | Three Rivers Consulting & Management ,llc |
| Address | 1122 N Main St Ste B Muskogee, Oklahoma, 74401 |
| Phone Number | (918)681-4988 |
News Archive
The move is designed to reduce the risk of unnecessary surgery, but some physicians may resist the effort. Women with low-risk pregnancies should be allowed to spend more time in labor, to reduce the risk of having an unnecessary C-section, the nation's obstetricians say.
Commenting on Edward Boyden's article, Ben Barres, Head of the Neuronal & Glial Cell Biology Section of Faculty of 1000 and Professor at Stanford University School of Medicine said: "There will probably be a Nobel prize for optogenetics someday as it has revolutionized our attempts to understand how the brain works. This article provides a fascinating insight into the birth of optogenetics and the roles of the major players."
Top Institute Pharma (TI Pharma) enables unique public-private collaborations that are extremely valuable for pharmaceutical research in the Netherlands. This can be read in the Midterm Review (MTR) of the Top Institute, which was published today. In the report, an independent committee chaired by Cees Veerman concludes that TI Pharma is well on its way to achieving the objectives that were determined at the time of its establishment. The institute addresses issues with marked social relevance, attracts international investments and has brought forth a group of quality researchers.
Health costs per person in Minnesota rose only 2.6 percent in 2010, about half the national average. Key factors in controlling costs were innovations by Minnesota's health plans – for example, more effective management of care for those with chronic diseases – and reduced demand for health care in a slow economy.
Schering-Plough Corporation today reported a proposed settlement, subject to Court approval, to resolve litigation seeking to enjoin the planned merger with Merck & Co., Inc., and other forms of relief.
› Verified 7 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
The move is designed to reduce the risk of unnecessary surgery, but some physicians may resist the effort. Women with low-risk pregnancies should be allowed to spend more time in labor, to reduce the risk of having an unnecessary C-section, the nation's obstetricians say.
Commenting on Edward Boyden's article, Ben Barres, Head of the Neuronal & Glial Cell Biology Section of Faculty of 1000 and Professor at Stanford University School of Medicine said: "There will probably be a Nobel prize for optogenetics someday as it has revolutionized our attempts to understand how the brain works. This article provides a fascinating insight into the birth of optogenetics and the roles of the major players."
Top Institute Pharma (TI Pharma) enables unique public-private collaborations that are extremely valuable for pharmaceutical research in the Netherlands. This can be read in the Midterm Review (MTR) of the Top Institute, which was published today. In the report, an independent committee chaired by Cees Veerman concludes that TI Pharma is well on its way to achieving the objectives that were determined at the time of its establishment. The institute addresses issues with marked social relevance, attracts international investments and has brought forth a group of quality researchers.
Health costs per person in Minnesota rose only 2.6 percent in 2010, about half the national average. Key factors in controlling costs were innovations by Minnesota's health plans – for example, more effective management of care for those with chronic diseases – and reduced demand for health care in a slow economy.
Schering-Plough Corporation today reported a proposed settlement, subject to Court approval, to resolve litigation seeking to enjoin the planned merger with Merck & Co., Inc., and other forms of relief.
› Verified 7 days ago
| Home Health Aides | 1 |
| Homemakers | 1 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 1 |
| Physicians | 0.25 |
| Registered Nurses | 2 |
| Total Employees | 6.25 |
|---|
News Archive
The move is designed to reduce the risk of unnecessary surgery, but some physicians may resist the effort. Women with low-risk pregnancies should be allowed to spend more time in labor, to reduce the risk of having an unnecessary C-section, the nation's obstetricians say.
Commenting on Edward Boyden's article, Ben Barres, Head of the Neuronal & Glial Cell Biology Section of Faculty of 1000 and Professor at Stanford University School of Medicine said: "There will probably be a Nobel prize for optogenetics someday as it has revolutionized our attempts to understand how the brain works. This article provides a fascinating insight into the birth of optogenetics and the roles of the major players."
Top Institute Pharma (TI Pharma) enables unique public-private collaborations that are extremely valuable for pharmaceutical research in the Netherlands. This can be read in the Midterm Review (MTR) of the Top Institute, which was published today. In the report, an independent committee chaired by Cees Veerman concludes that TI Pharma is well on its way to achieving the objectives that were determined at the time of its establishment. The institute addresses issues with marked social relevance, attracts international investments and has brought forth a group of quality researchers.
Health costs per person in Minnesota rose only 2.6 percent in 2010, about half the national average. Key factors in controlling costs were innovations by Minnesota's health plans – for example, more effective management of care for those with chronic diseases – and reduced demand for health care in a slow economy.
Schering-Plough Corporation today reported a proposed settlement, subject to Court approval, to resolve litigation seeking to enjoin the planned merger with Merck & Co., Inc., and other forms of relief.
› Verified 7 days ago
| Hometown Hospice Location: 2307 South York, Muskogee, Oklahoma, 74403 Phone: (918) 681-4988 |
| Cima Hospice Location: 2421 South York Street, Suite 15, Muskogee, Oklahoma, 74403 Phone: (918) 681-4988 |
| Rivercross Hospice Location: 222 S 32nd Street, Muskogee, Oklahoma, 74401 Phone: (918) 681-4988 |
| Compassus-muskogee Location: 2913 Azalea Park Drive, Muskogee, Oklahoma, 74401 Phone: (918) 681-4988 |